International study of the prevalence and outcomes of infection in intensive care units

By Jay S. Steingrub. 2009

1,569 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Chang-Ro Lee
2. Jung Hun Lee
3. Moonhee Park
4. Kwang Seung Park
5. I. K. Bae
6. Young Bae Kim
7. C. Cha
8. B. Jeong

Citations in the corpus

• DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? (2014, unknown): “prescribed antibiotics at any one time [1].”
• Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. (2013, background): “Although this commensal organism normally colonizes mucosal surfaces in an asymptomatic manner, it can become one of the most significant causes of a disabling and lethal infection (Wisplinghoff et al., 2006; Vincent et al., 2009).”
• Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges (2016, unknown): “53—the highest of all Gram-negative species (192).”
• Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options (2017, background): “Most A. baumannii infections occur in critically ill patients in the intensive care unit (ICU) setting (Fournier and Richet, 2006) and account for up to 20% of infections in ICUs worldwide (Vincent et al., 2009).”
• Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. (2016, unknown): “available or predictable, we had to exclude these studies from analyses; however, they reveal that ICU admissions rates for infections and sepsis are comparable throughout the world, even though causative organisms differ remarkably between continents (45, 46) Furthermore, data on population-level i”